Back to search

Article

Programmable DNA Nanocages Enhance Levodopa Delivery for Neuroprotection in a Zebrafish Model of Parkinson’s Disease

2026-08-04

Abstract excerpt

Parkinson’s Disease (PD) is the second-most prevalent neurodegenerative disease, often characterized by neural motor dysfunction, oxidative stress, and dopamine receptor malfunction leading to improper dopamine levels in the system. DNA tetrahedron nanostructures are a promising drug delivery agent due to their biocompatibility and properties of controlled and sustained release. In this study we evaluated the pote...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c1582de1-63a4-5568-a46e-ea28c35d08ba
DOI
10.64898/2026.08.04.742731
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Programmable DNA Nanocages Enhance Levodopa Delivery for Neuroprotection in a Zebrafish Model of Parkinson’s DiseaseDOI 10.64898/2026.08.04.742731
Select a neighboring publication to make it the new centre.